A Louisiana court room ordered the Japanese drug making company, Takeda,
to pay $9 billion in punitive damages after a federal court jury said
it hid cancer risks of their Actos diabetes medicine.
Studies have shown that there is an increased risk of users devloping bladder
cancer after taking Actos for a year or more. Actos entered the market
in 1999 by Takeda Pharmaceuticals and Eli Lilly. Before becoming available
on the markets, evidence had shown an increase risk of bladder tumors
in animals. In the mid 2000′s, epidemiological evidence began to
mount that raised the question whether or not the tumor risk was present
The lawsuit alleged that Takeda did not take serious the concerns about
the drug’s cancer potential and put many at risk. Even worse, it
was alleged that Takeda misled regulators to protect billions in sales.
Personal injury and medical malpractice attorneys, Williams DeClark Tuschman,
are now offering free consultation for anyone who may have come in contact
with the Actos drug. For more information on the Actos litigation, please contact
Williams DeClark Tuschman today or call our office at 419-241-7700. We are more than happy to answer
any questions you may have. After our free consultation we will assist
you in the next steps of the appropriate action to take.